Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients

Scandinavian Journal of Gastroenterology
Tae Seop LimSang Hoon Ahn

Abstract

As data on the effectiveness of tumor markers in detecting hepatocellular carcinoma (HCC) in cirrhotic patients are limited, we investigated the diagnostic accuracy of alpha-fetoprotein (AFP), protein induced by vitamin K absence or antagonist-II (PIVKA-II), and Lens culinaris agglutinin-reactive fraction of AFP (AFP-L3). This retrospective study enrolled 361 cirrhotic patients with HCC, and 276 cirrhotic patients without HCC occurrence. Most patients were men (n = 431, 67.7%); the median age was 57.0 years. The main etiology of chronic liver disease was chronic hepatitis B (n = 467, 73.3%). The sensitivity and specificity of combined three biomarkers was 87.0 and 60.1% in overall HCC, and 75.7 and 60.1% in early HCC, respectively (cutoff: 20 ng/mL for AFP, 40 mAU/mL for PIVKA-II, and 5% for AFP-L3). The area under the receiver operating characteristic curve (AUROC) for HCC diagnosis was 0.765 (95% confidence interval [CI], 0.728-0.801) for AFP; 0.823 (95% CI, 0.791-0.854) for PIVKA-II; and 0.755 (95% CI, 0.718-0.792) for AFP-L3. The AUROC for early HCC diagnosis was 0.754 (95% CI, 0.691-0.816) for AFP, 0.701 (95% CI, 0.630-0.771) for PIVKA-II, and 0.670 (95% CI, 0.596-0.744) for AFP-L3. Combining the three tumor markers increa...Continue Reading

References

Dec 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K Taketa
Sep 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K ShirakiT Nakano
Jun 24, 1993·The New England Journal of Medicine·Y SatoS Nagataki
Feb 20, 2002·Journal of Gastroenterology and Hepatology·H OkaUNKNOWN Collaborative Hepato-Oncology Study Group of Japan
Mar 11, 2005·Best Practice & Research. Clinical Gastroenterology·Man-Fung Yuen, Ching-Lung Lai
May 25, 2007·Cancer Biomarkers : Section a of Disease Markers·Michael L VolkJorge A Marrero
Feb 23, 2010·Seminars in Liver Disease·Alejandro FornerJordi Bruix
Dec 9, 2010·The Oncologist·Alan P VenookLaura Ladrón de Guevara
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
Sep 29, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sufen ShangLaura Beretta
Mar 20, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver, UNKNOWN European Organisation For Research And Treatment Of Cancer
Jun 1, 2012·Liver Cancer·Do Young Kim, Kwang-Hyub Han
Nov 14, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Philip J JohnsonShinji Satomura

❮ Previous
Next ❯

Citations

Aug 29, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jonggi ChoiYoung-Suk Lim
May 10, 2020·Journal of Viral Hepatitis·Tae Seop LimUNKNOWN Korean Transient Elastography Study Group
Oct 3, 2018·Journal of Clinical and Translational Hepatology·Ka Wing MaChung Mau Lo
Jul 6, 2020·Cancer Biomarkers : Section a of Disease Markers·Gabriele RiccoMaurizia Rossana Brunetto
Dec 28, 2017·Cancer Biomarkers : Section a of Disease Markers·Gabriele RiccoMaurizia Rossana Brunetto
Apr 16, 2020·The Journal of International Medical Research·Youde LiuYinghua Zhang
Mar 7, 2020·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Xiaoting SongChunyan Zhang
Feb 11, 2021·Biomedicines·Nurbubu T MoldogazievaAlexander A Terentiev
Apr 16, 2021·The Cochrane Database of Systematic Reviews·Agostino ColliGiovanni Casazza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Related Papers

Best Practice & Research. Clinical Gastroenterology
Man-Fung Yuen, Ching-Lung Lai
Gan to kagaku ryoho. Cancer & chemotherapy
Sadanori Kubo, Masaaki Matsukawa
Nihon rinsho. Japanese journal of clinical medicine
Ryosuke TateishiKazuhiko Koike
© 2021 Meta ULC. All rights reserved